Publication

NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting nectin-4 in participants with advanced or metastatic urothelial carcinoma or other solid tumors (trial in progress)

Baldini, C.
; 
Patnaik, A.
; 
Lakhani, N.
; 
Call, J.
; 
Galsky, M.
; 
Garmezy, B.
; 
Wei, A.
; 
Carter, Louise
; 
Powles, T.
; 
Siefker-Radtke, A.
... show 10 more
Citations
Altmetric:
Abstract
Authors
Baldini, C.
Patnaik, A.
Lakhani, N.
Call, J.
Galsky, M.
Garmezy, B.
Wei, A.
Carter, Louise
Powles, T.
Siefker-Radtke, A.
O'Donnell, P. H.
Kitano, S.
Castellano, D. E.
Shinde, R.
Joshua, A. M.
Balbas, M.
Han, H.
Chang, A. E.
Gao, X.
Iyer, G.
Affiliation
The University of Manchester and The Christie NHS Foundation Trust, Division of Cancer Sciences, Manchester, United Kingdom
Description
Date
2024
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Baldini C, Patnaik A, Lakhani N, Call J, Galsky M, Garmezy B, et al. NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting Nectin-4 in participants with advanced or metastatic urothelial carcinoma or other solid tumors (Trial in Progress). EUROPEAN JOURNAL OF CANCER. 2024 OCT;211:S66-S. PubMed PMID: WOS:001345547300158. English.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/627402
Embedded videos